Moneycontrol
HomeNewsBusinessEconomyIndia witnessing V-shaped recovery during unlock period: CEA Subramanian
Trending Topics

India witnessing V-shaped recovery during unlock period: CEA Subramanian

In terms of outlook going forward, Subramanian said a few sectors clearly demonstrate the V-shape recovery

September 01, 2020 / 11:18 IST
Story continues below Advertisement

India is witnessing a V-shaped recovery as the economy unlocks after the COVID-19 necessitated lockdown, Chief Economic Advisor Krishnamurthy Subramanian said.

Speaking to CNBC-TV18, Subramanian said indicators point to a V-shaped recovery.

Story continues below Advertisement

On the outlook in terms of revival and recovery, Subramanian emphasised that the GDP fall was expected due to the global COVID-19 pandemic, noting that the number of countries registering decrease in per capita GDP this year “is the highest in one-and-a-half century.”

“The April-June quarter (Q1) especially was a time when the global and Indian economy was in lockdown with several restrictions on economic activity and this is not entirely unexpected. In terms of outlook going forward, we have been witnessing a V-shaped recovery as the economy has been unlocked and a few sectors clearly demonstrate that,” he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show